Home > News : News & Events  
 
Pipeline

News & Events

POSITIVE RESULTS IN INFLAMMATORY EYE DISEASE TREATMENT

Xigen announces the online publication of successful Phase II results for its lead compound Brimapitide (XG-102) in the American Journal of Ophthalmology. - January 2017


  Top